- With Mayo Clinic genetic counselor
Carrie A. Zabel, M.S., C.G.C.
read biographyclose windowBiography of
Carrie A. Zabel, M.S., C.G.C.
Carrie A. Zabel, M.S., C.G.C.
"We must begin now to prepare for the future; we cannot wait until the details are known or fully understood."*
— David B. Schowalter, M.D., Ph.D., former Mayo geneticist, (*posthumous)
Carrie A. Zabel, M.S., C.G.C., is a board-certified genetic counselor who specializes in hereditary cancer syndromes. One of her main professional interests is the family medical history.
"Recognizing features in the family history which may suggest an underlying single gene disorder can have a huge impact on families," she says. "Identifying a genetic susceptibility gene can allow family members to more accurately understand their risk of disease and empower those who have an increased genetic susceptibility to take control of their medical management and lifestyle factors which may influence this risk."
She received her B.S. in biology from the University of Wisconsin-La Crosse in 2002 and M.S. in genetic counseling from the University of Minnesota in 2004.
She was a clinical genetic counselor at the Marshfield Clinic in Marshfield, Wis., before joining Mayo Clinic in August 2006 as a genetic counselor and educator for the grant-funded Mayo Eisenberg Genomics Education Program. During her time in Wisconsin, she was also an active member of the metabolic subcommittee of the state Newborn Screening Program and co-facilitated a phenylketonuria clinic.
At Mayo Clinic, she provides physician and staff education about clinically relevant topics in genomics. She also manages multiple education projects championed by Mayo Clinic physicians and is a faculty member for Mayo Medical School. In addition to her education roles, she sees adult patients in the Department of Medical Genetics.
Latest entries
- Genetic testing for breast cancer: Ancestry makes a difference
Jan. 27, 2010
- Should our genes be patented?
Dec. 22, 2009
- Exploring the causes of autism
Dec. 2, 2009
- Series of tests identifies cystic fibrosis
Nov. 10, 2009
- Predictive genetic testing: What are the risks?
Sept. 5, 2009
Mayo Clinic Health Manager
Get free personalized health guidance for you and your family.
Get Started
About our e-newsletters
- Free e-newsletters
- Mayo Clinic expertise
- We do not share your e-mail address
Housecall, our weekly general-interest e-newsletter, keeps you up to date on a wide variety of health topics with timely, reliable, practical information, recipes, blogs, questions and answers with Mayo Clinic experts and more. Our biweekly topic-specific e-newsletters also include blogs, questions and answers with Mayo Clinic experts, and other useful information that will help you manage your health.
Housecall Archives
Mayo Clinic Housecall
Stay up to date on the latest health information.
What you get
- Free weekly e-newsletter
- Mayo Clinic expertise
- Recipes, tools and other helpful information
- We do not share your e-mail address
Genetics blog
-
July 11, 2009
Blog: Prenatal testing options
By Carrie A. Zabel, M.S., C.G.C.
Pregnancy is an exciting time, but it can also be challenging and full of decisions. Each clinic visit seems to hold new options, including options to learn about your baby's genetic health before he or she is born.
Some individuals decline all genetic screening and prenatal testing; this is a perfectly acceptable choice. Others choose a form of genetic screening to determine the chance that their baby might have a chromosome abnormality, like Down syndrome.
This can be done by either a first trimester screen or quad marker screen. The main difference between the two is when they take place. A first trimester screen will give you this information between weeks 11 and 14 of pregnancy; a quad marker screen usually doesn't take place until week 16.
A second-trimester ultrasound is also considered a prenatal screening test. Although it won't tell you details about the baby's genetic makeup, it will provide an assessment of the baby's anatomy to see if any birth defects exist. Since certain birth defects can be associated with genetic conditions, it may indirectly give you information about the chance that your baby has a genetic condition.
One of the main benefits of prenatal screening is that you can learn the chance that your baby has genetic condition without putting the pregnancy at risk; this is different than diagnostic testing. Diagnostic testing will give you a definitive answer about the baby's number and overall structure of chromosomal material, but carries with it a small risk for miscarriage.
Two options for diagnostic prenatal testing include amniocentesis and chorionic villus sampling (CVS). Amniocentesis is generally done after 14 weeks of pregnancy; CVS is done between weeks 10 and 12 of pregnancy. CVS is a slightly more invasive test, but provides the information at an earlier gestational age. However, it does carry a slightly higher risk for miscarriage than amniocentesis.
Meeting with a genetic counselor can be exceptionally helpful in making a decision about the best options to pursue, if any, during your pregnancy. One of the most important questions to ask yourself during this time is "What will you do with the information you learn?" Please, share your experiences and feedback for our readership.
2 comments posted
November 11, 2009 4:42 p.m.
Carrie, thanks for your time keeping up with this blog. My wife and I had prenatal testing two years ago when she was pregnant. I was so grateful that I had access to these types of services, yet there are so many people that don't have access because they don't live in a big city or just don't work with quality health professionals. As a result, I worked with our own genetic counselor, who was working for Genzyme at the time, to help me launch AccessDNA to help others like me. Among other things, I felt it was very important to have a "search by zip code" directory so others could find a genetic professional in their area.
- Lee
September 30, 2009 2:55 p.m.
Thanks for your blog Carrie! I am interested in locating women who are uncertain about whether they want to have prenatal testing. If you come across women who are ambivalent, I would be very grateful if you let them know about my NIH study. We are trying out new innovative ways to enhance decision making. Participation takes about 30 minutes. The link to the site is:http://research.nhgri.nih.gov/SBRB/Prenata
l/ Barb Biesecker - Barb
2 comments posted